Drug Profile


Alternative Names: NNC 01756; NNC 0756; NNC 756

Latest Information Update: 29 Oct 2004

Price : $50

At a glance

  • Originator Novo Nordisk
  • Class Antipsychotics; Benzazepines; Benzofurans; Small molecules
  • Mechanism of Action Dopamine D1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Psychotic disorders

Most Recent Events

  • 27 Oct 2004 Discontinued - Phase-I for Psychotic disorders in Denmark (unspecified route)
  • 22 Nov 1999 No-Development-Reported for Psychotic disorders in Denmark (Unknown route)
  • 25 Jan 1996 A preclinical study has been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top